La Jolla Institute researchers joined a PNAS study that introduced "superHLA," a computational pipeline that scanned more than 190,000 peptides and validated 24 superbinders. The method could help identify vaccine targets that work across diverse genetic backgrounds.

A unanimous DRC vote advances a $25M plan to remake the long-idle St. Petersburg Science Center into an AI hub with classrooms, labs and startup space.

UC San Diego researchers developed a non‑destructive “milking” method to extract therapeutic plant particles under simulated space stressors, pointing to on‑demand medicines for long missions.

Stockton police have equipped officers with Axon body cameras that translate 50+ languages in real time. Officials call it a service boost; advocates want tighter oversight.

UC San Diego researchers found SynCav1 preserved memory and neuron structure in mice with TDP‑43 pathology, suggesting a neuron‑focused path forward for dementia research.

The Oregon Supreme Court struck a petition after filings included AI‑generated fake citations, and a separate order imposed a $500 sanction while allowing a corrected response.

A Cleveland Clinic anesthesiologist turned her Parkinson’s diagnosis into a research and racing mission — joining a cycling trial researchers say may slow disease.

Albany approved S9051 this week to bar AI chatbot features that can harm or manipulate kids; the move was driven by parents testimony and advocacy groups.

A sudden selloff in semiconductor stocks erased more than $1 trillion Friday, pulling down Nvidia, Micron and other AI-era winners. Markets turned volatile as investors reassessed expectations.

Houston‑born Cemvita completed a 75,000‑liter FermOil fermentation in Ghent, turning biodiesel glycerin into a potential SAF feedstock.

Eli Lilly acquired Houston startup CrossBridge Bio for up to $300M, picking up a UTHealth-originated dual‑payload ADC and lead candidate CBB‑120 as it nears clinical testing.

Flourish surfaced from stealth with $500M and a $2.5B valuation, backed by Bezos and top VCs, promising a low‑power 'Cortex AI' that blends neuroscience and machine learning.

Anthropic warns that AI may soon be able to self‑improve and urges a verifiable global "brake" to slow frontier work while researchers study risks.